Granite Group Advisors, LLC Astrazeneca PLC Transaction History
Granite Group Advisors, LLC
- $177 Billion
- Q4 2025
A detailed history of Granite Group Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Granite Group Advisors, LLC holds 2,861 shares of AZN stock, worth $255,773. This represents 0.15% of its overall portfolio holdings.
Number of Shares
2,861
Previous 2,861
-0.0%
Holding current value
$255,773
Previous $219 Million
19.83%
% of portfolio
0.15%
Previous 0.13%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,545Shares Held
502MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...